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Background: In recent years numerous studies have undertaken to measure the impact of patents, material
transfer agreements, data-withholding and commercialization pressures on biomedical researchers. Of particular
concern is the theory that such pressures may have negative effects on academic and other upstream researchers.
In response to these concerns, commentators in some research communities have called for an increased level of
access to, and sharing of, data and research materials. We have been studying how data and materials are shared
in the community of researchers who use the nematode Caenorhabditis elegans (C. elegans) as a model organism
for biological research. Specifically, we conducted a textual analysis of academic articles referencing C. elegans,
reviewed C. elegans repository request lists, scanned patents that reference C. elegans and conducted a broad
survey of C. elegans researchers. Of particular importance in our research was the role of the C. elegans Gene
Knockout Consortium in the facilitation of sharing in this community.
Results: Our research suggests that a culture of sharing exists within the C. elegans research community.
Furthermore, our research provides insight into how this sharing operates and the role of the culture that
underpins it.
Conclusions: The greater scientific community is likely to benefit from understanding the factors that motivate C.
elegans researchers to share. In this sense, our research is a ‘response’ to calls for a greater amount of sharing in
other research communities, such as the mouse community, specifically, the call for increased investment and
support of centralized resource sharing infrastructure, grant-based funding of data-sharing, clarity of third party
recommendations regarding sharing, third party insistence of post-publication data sharing, a decrease in patenting
and restrictive material transfer agreements, and increased attribution and reward.
Background
In recent years numerous studies have undertaken to
measure the impact of patents, material transfer agree-
ments (MTAs), data-withholding and commercialization
pressures on biological researchers [1,2]. At issue, and
perhaps the impetus behind such studies, is the question
of whether these factors have negative effects on the
s c o p ea n dq u a l i t yo fu p s t r e a mr e s e a r c h .I nac l a s s i c
paper on this subject, Heller and Eisenberg hypothesized
that the proliferation of intellectual property rights in
biomedical research had the potential to create an
‘anticommons’, whereby resources were prone to under-
use because of the ability of multiple (patent) owners to
exclude others from use of those resources [3]. Though
scholars continue to debate the existence, scope and
degree of that anticommons in the various fields of biol-
ogy [1,2], some research communities have called for an
increased level of access to, and sharing of, data and
research materials as a result of these concerns [4,5].
As part of our work with the Intellectual Property and
Policy Research Group (IPPRG) at the University of
British Columbia, we have studied how data and materi-
als are shared in the community of researchers who use
the nematode Caenorhabditis elegans (C. elegans)a sa
model organism for biological research. Specifically, we
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encing C. elegans, reviewed C. elegans repository request
lists, scanned patents that reference C. elegans and con-
ducted a broad survey of C. elegans researchers. Of par-
ticular importance in our research was the role of the
C. elegans Gene Knockout Consortium (GKC) in the
facilitation of sharing in this community. The GKC is a
collaboration between three C. elegans labs, located in
Canada, Japan, and the United States, whose mandate is
to produce null alleles of all known genes in the C. ele-
gans genome - creating knockout strains - and to share
those strains with the public pre-publication [6].
Our purpose in writing this commentary is twofold.
First, our study of sharing amongst C. elegans research-
ers provides insight into how sharing operates in this
unique community and the role of the culture that
underpins it. We believe that the greater scientific com-
munity can benefit from understanding these practices,
as the C. elegans research community may stand as a
model in this regard. In this sense, our research stands
as a ‘response’ to calls for a greater amount of sharing
in other research communities, specifically, to Schofield
et al’s ‘Rome Agenda’: a call for the creation of such a
‘research commons’ in the mouse research community
[4]. Secondly, our study sheds light on the existence, or
lack thereof, of drawbacks to upstream resource sharing,
and explores whether an open system can still be pro-
ductive and competitive.
Methods
We adopted a four-pronged approach to measuring the
sharing of data and materials within the C. elegans
research community. Our belief was that this broad
range of data would not only highlight objective mea-
sures of the existence of a research commons but also
the subjective reasons behind such practices.
The first ‘prong’ of our research involved reviewing
requests for C. elegans knockout strains from the Cae-
norhabditis Genetics Center (CGC). The CGC, housed
at the University of Minnesota, collects, maintains and
distributes stocks of C. elegans, and is the central reposi-
tory for this research organism. We tracked references
to strains produced by the labs that comprise the GKC
and deposited in the CGC, in an attempt to measure
the use of publicly available strains of C. elegans (See
figure 1 for a diagram of the relationship between the
GKC and CGC).
The second element of our approach was to quantify
and examine references to GKC-produced C. elegans
strains in academic peer-reviewed publications. We sur-
mised that an important marker of the existence of a
research commons was the attribution of pre-publica-
tion shared materials and thus sought to determine
whether researchers who used the publicly shared
strains attributed the creation of such strains to the
C G Ca n dG K C[ 7 ] .T h el i t e r a t u r es e a r c hw a sd o n e
using WormBase, the central C. elegans database [8];
through which we identified articles that referenced the
use of C. elegans. Articles were filtered to exclude those
publications in which C. elegans was not a key compo-
nent in the published research.
A related, third facet of our research was a search for
patents that referred to C. elegans. We used the search
term ‘C. elegans’ in the United States Patent and Trade-
mark Office patent search engine, collecting and review-
ing references to C. elegans in both issued patents and
pending patent applications. Our hypothesis was that
this data would bear upon the question of whether shar-
ing within a research community correlates in any man-
ner with patenting.
The final, and most substantive dimension of our
research was the development and dissemination of an
online survey to scientific researchers who either work
with C. elegans as a model research organism or work
in an organization that uses C. elegans in their research.
The survey was a web-based questionnaire that included
48 close-ended and 28 open-ended questions, asking
researchers about their research experiences with C. ele-
gans, their research practices, use of research materials,
patenting practices and demographic information (See
additional file 1 for the survey). After obtaining approval
from the UBC Behavioral Research Ethics Board, our
sample was drawn from registered members of Worm-
Base, whose names appear in at least one C. elegans
related publication included in WormBase. We excluded
researchers who had retired, were no longer involved in
laboratory work, or who were no longer working with
C. elegans as a model organism. This group of excluded
individuals was self-identified, as the first page of the
survey invited only those researchers who were currently
engaged in C. elegans research to complete the survey.
We used a mixed methods approach to sampling
researchers, and sent out five waves of survey invitations
according to our list of 652 registered C. elegans research-
ers. We followed this invitation to action with a simple
random sample of 400 respondents who received an addi-
tional email encouraging them to respond to the survey.
We also used a snow-ball sampling method to expand our
pool of potential respondents to researchers in all aspects
of C. elegans research, requesting any C. elegans researcher
who received the survey request to forward the link to
other individuals who were involved in any aspect of C.
elegans related research. Ultimately we received 680
responses from our sample of C. elegans researchers.
Results
Among survey respondents, 410 (60.3%) reported having
deposited knockout strains into the CGC. As of
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deposited in the CGC were deposited by the three labs
that comprise the GKC. Survey respondents reported
receiving CGC strains (94.4% of respondents) and GKC
strains specifically (76.9% of respondents). Furthermore,
survey respondents often commented on the significance
of the publicly available strains to their work, especially
those working in small labs: “I have a very small lab and
don’t have the resources to make my own knockouts.”
Since the establishment of the GKC in 2001, over one
thousand academic references have been made to strains
produced by the Canadian and American components of
the consortium, the breadth of publications ranging
from Nature to the Worm Breeder’s Gazette.T h eq u a n -
tity of publications referencing the use of GKC strains
has steadily increased since its inception, from 22 in
2001 to 212 in 2009 [9]. Of those articles that reference
using these strains, 95 report using more than one GKC
produced strain.
The C. elegans researchers who responded to our sur-
vey indicate that for the most part they did not use for-
mal intellectual property mechanisms (e.g. MTAs) when
acquiring and distributing data and research materials:
453 (66.6%) and 544 (79.7%), respectively. Of particular
significance is the fact that the American and Canadian
components of the GKC deposit knockout strains in the
CGC without requiring requestors to complete an MTA
for use of the strains. While the lab in Japan does
require an MTA for use of the strains they produce,
researchers did not once mention, in their survey
responses, that MTAs impeded their research. In addi-
tion to the informality with which they share materials,
177 (26.0%) of survey respondents report being listed as
an inventor on a patent application. While this is a fairly
high percentage for a ‘basic research’ community, it may
be significant that many respondents reported that
when filing for patents they did so at the request of
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related patents granted in the United States has
increased steadily from 1976 to 1999, and since then has
held steady at about 250-300 granted patents a year. C.
elegans were usually referenced as prior art to the
claimed invention, most often used in early stages of
product exploration and/or development.
A number of survey questions asked C. elegans
researchers about their perceptions toward data-sharing
and research materials (See additional file 1 for sample
survey questions). The majority of worm researchers
surveyed report sharing data and research pre- and
post-publication, regardless of the requirements of their
funding bodies. In addition, most respondents reported
the belief that C. elegans samples should be shared
freely: 518 (76.2%) agreed that one should not restrict
access or use of scientific data; 616 (90.6%) reported
that they encourage their colleagues to share data and
research materials. When respondents were asked about
their views on commercialization, they were much more
divided in their response. Responses were roughly evenly
split between those who agreed that granting exclusivity
in exchange for disclosure through intellectual property
rights preserves incentives to innovate, and those that
disagreed. Most respondents did agree however that
focusing on research with potential commercial outputs
may impair the free exchange of materials. Finally,
roughly a third of respondents reported that they would
create a private-start up company should they have the
opportunity.
Discussion
Our analysis of this diverse data set suggests that a
scientific commons, or culture of sharing, exists within
the C. elegans community. In this sense, the data speaks
to the viability of recent calls for increased sharing in
other research communities and provides insight
into what practices may successfully facilitate such
sharing [4].
Firstly, our research demonstrates the strength gained
from openly available, publicly funded infrastructure.
Within the worm community such infrastructure centra-
lizes the sites of resource production (GKC), housing of
experimental resources (CGC) and online research
material (WormBase). Centralized funding of data pro-
duction and repository projects creates opportunities for
smaller scale researchers to focus their work on hypoth-
esis driven experiments rather than laborious produc-
tion, as well as increases the productivity of such
research. It is simply more cost-effective to create a
knockout once, and share it, than the parallel produc-
tion of identical knockouts. This practice also allows
better data comparison across C. elegans labs, given the
standardization of knockout strains. Furthermore, if
granting organizations are in the business of funding
multiple hypothesis driven research projects, it may be
more cost-effective for these bodies themselves to fund
projects that centrally produce research materials from
which other researchers can draw.
While most C. elegans researchers reported sharing
absent explicit directions to do so by funding bodies,
the practice of data-sharing varies among researchers
and research communities. Some researchers reported
sharing data only when explicitly asked to do so, while
others reported regular contributions to central reposi-
tories. It may be that clear recommendations for sharing
by funding agencies would ‘normalize’ the process of
sharing, however, within the worm community such
directives seem to be unnecessary. That said, given the
lack of a tradition of sharing within other research com-
munities, it may be important that funding bodies give
such recommendations and direction to facilitate shar-
ing. Similarly, our study of sharing in the worm commu-
nity suggests that while pre- and post-publication of
data and materials does occur in the worm community,
it is not because of the insistence of third parties (scien-
tific journals, grant reviewers, and funding bodies).
Rather, we hypothesize that sharing occurs as a result of
the ethos found within the community and first
espoused by Sydney Brenner and John Sulston [10].
From our study, it is clear that while C. elegans strains
are widely used as research tools, the large amount of
sharing does not preclude patenting, in spite of the sta-
ted preference by prominent members of the research
community for the public domain [10]. It is worth not-
ing however that there is very little patenting of the
organism itself, due perhaps to the lack of direct market
applicability of the results of C. elegans research. In
addition, the fact that specific knockouts or C. elegans
DNA sequences are generally not patented as research
tools may facilitate sharing within this research commu-
nity. Certainly, post-publication dissemination and
MTA-free sharing may be more likely where researchers
are not overly concerned with protecting proprietary
interests granted by patents.
Our survey data suggests that WormBase, the central
resource for data, metadata and related computational
tools for worm researchers, plays a significant role in
facilitating the C. elegans research commons. The
WormBase management and curatorial team set stan-
dards for data and metadata and implement new stan-
dards as they develop. The WormBase curatorial team
also invests in computational tools and reviews data
before it appears online. As a result of these efforts,
issues related to data standardization are addressed by
the community. Given the success of WormBase in the
standardization of tools and information for C. elegans
researchers, other research communities would be wise
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invest time and resources into them if they do.
Like other research communities, members of the C.
elegans community are requested to recognize the con-
tribution of their colleagues when using pre-publication
shared strains, data and materials. In the worm commu-
nity, researchers are generally asked to acknowledge
g r o u p s ,s u c ha sG K Ca n dC G C ,w h e nu s i n gs h a r e d
materials, and are not required to add additional author-
ship unless the researcher has made a major contribu-
tion to their work. Even if a researcher does not
explicitly acknowledge the source of the strains
employed in her research, the nomenclature of strains
identifies those originating from the GKC. Thus, the
phenomenon of pre-publication sharing is visible to all.
Conclusions
Our research suggests that a culture of sharing exists
within the C. elegans research community. Such a prac-
tice of sharing is informative for the establishment of a
creative commons within other research communities.
Specifically, our research speaks to the strength of Scho-
f i e l de ta l ’s call for increased investment and support of
centralized resource sharing infrastructure, grant-based
funding of data-sharing, clarity of third party recom-
mendations regarding sharing, third party insistence of
post-publication data sharing, a decrease in patenting
and restrictive MTAs and increased attribution and
reward.
Additional material
Additional file 1: C elegans Researcher Survey. Additional file 1
contains the online survey, which was completed by all survey
respondents.
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